Related Experiment Video
Updated: Aug 19, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
Carcinoembryonic antigen-related cell adhesion molecule (CEACAM)-binding recombinant polypeptide confers protection
Darryl J Hill1, Andrew M Edwards, Helen A Rowe
1Department of Pathology and Microbiology, University of Bristol, Bristol, BS8 1TD, UK.
Abstract:
The human-specific pathogens Neisseria meningitidis, N. gonorrhoea, Haemophilus influenzae and Moraxella catarrhalis share the property of targeting the carcinoembryonic antigen (CEA)-related cell adhesion molecules (CEACAMs) expressed on human epithelia. CEACAMs are signalling receptors implicated in cell adhesion and regulation of several physiological functions. Their targeting by pathogens can lead to tissue invasion. Although the CEACAM-binding ligands of the bacteria are structurally diverse, they target a common site on the receptor. We have generated a recombinant polypeptide that blocks the interactions of the mucosal pathogens with human epithelial cells and antibodies against it inhibit M. catarrhalis interactions with the receptor. As such, it is a potential antimicrobial agent to prevent infection via a strategy unlikely to promote bacterial resistance and a vaccine candidate against M. catarrhalis. In addition, it could serve more widely as a novel research tool and as a potential therapeutic agent in CEACAM-based physiological disorders.
Insights
Researchers developed a novel polypeptide targeting common bacterial adhesion sites on human CEACAMs. This agent shows potential as an antimicrobial to prevent infections and a vaccine against Moraxella catarrhalis.
Area of Science:
- Microbiology
- Immunology
- Cell Biology
Background:
- Specific human pathogens like Neisseria meningitidis, N. gonorrhoea, Haemophilus influenzae, and Moraxella catarrhalis target carcinoembryonic antigen (CEA)-related cell adhesion molecules (CEACAMs) on human epithelial cells.
- CEACAMs are signaling receptors involved in cell adhesion and physiological functions; pathogen targeting can lead to tissue invasion.
- Bacterial ligands targeting CEACAMs are structurally diverse but bind to a common site on the receptor.
Purpose of the Study:
- To develop a therapeutic agent and vaccine candidate targeting the common CEACAM-binding site used by mucosal pathogens.
- To investigate the potential of a recombinant polypeptide as an antimicrobial and research tool.
Main Methods:
- Generation of a recombinant polypeptide designed to block pathogen interaction with CEACAMs.
- Testing antibodies against the polypeptide to inhibit Moraxella catarrhalis interaction with CEACAMs.
Main Results:
- The recombinant polypeptide effectively blocks interactions between mucosal pathogens and human epithelial cells.
- Antibodies against the polypeptide inhibit Moraxella catarrhalis interactions with CEACAMs.
Conclusions:
- The developed polypeptide is a potential antimicrobial agent offering a strategy to prevent infections with reduced risk of bacterial resistance.
- The polypeptide is a promising vaccine candidate against Moraxella catarrhalis and a valuable research tool for CEACAM-related studies and disorders.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...
Structure of Cadherins
Respiratory Syncytial Virus Disease

